Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the potential biological significance of cuproptosis-related gene LIPT2 in pan-cancer prognosis and immunotherapy. | Sci Rep | 2023 | 38129565 | PubTator, text mining | PubMed |
| Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. | Res Sq | 2023 | 38106039 | PubTator, text mining | PubMed |
| An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review. | Cureus | 2023 | 38054148 | PubTator, text mining | PubMed |
| Clinical and functional analysis of the germline TP53 p.K164E acetylation site variant. | Cold Spring Harb Mol Case Stud | 2023 | 38050059 | PubTator, text mining | PubMed |
| Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers. | Heliyon | 2023 | 38027682 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| The Dmc1 recombinase physically interacts with and promotes the meiotic crossover functions of the Mlh1-Mlh3 endonuclease. | bioRxiv | 2023 | 38014100 | PubTator, text mining | PubMed |
| In Vitro Models of Head and Neck Cancer: From Primitive to Most Advanced. | J Pers Med | 2023 | 38003890 | PubTator, text mining | PubMed |
| Systematic Review of Genetic Polymorphisms Associated with Acute Pain Induced by Radiotherapy for Head and Neck Cancers. | Clin Transl Radiat Oncol | 2023 | 37954025 | PubTator, text mining | PubMed |
| Ipsilateral synchronous papillary renal neoplasm with reverse polarity and urothelial carcinoma in a renal transplant recipient: a rare case report with molecular analysis and literature review. | Diagn Pathol | 2023 | 37924117 | PubTator, text mining | PubMed |
| Personalised neoantigen-based therapy in colorectal cancer. | Clin Transl Med | 2023 | 37921274 | PubTator, text mining | PubMed |
| Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma. | bioRxiv | 2023 | 37905107 | PubTator, text mining | PubMed |
| Chemical Insights into Oxidative and Nitrative Modifications of DNA. | Int J Mol Sci | 2023 | 37894920 | PubTator, text mining | PubMed |
| Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities. | Cancers (Basel) | 2023 | 37894343 | PubTator, text mining | PubMed |
| Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma. | Res Sq | 2023 | 37886584 | PubTator, text mining | PubMed |
| COLORECTAL CANCER: HISTOPATHOLOGICAL PROFILE AND PREVALENCE OF DNA REPAIR SYSTEM DEFICIENCY IN PATIENTS SUBMITTED TO SURGICAL TREATMENT IN A UNIVERSITY HOSPITAL. | Arq Bras Cir Dig | 2023 | 37878975 | PubTator, text mining | PubMed |
| Genetic modifiers of repeat expansion disorders. | Emerg Top Life Sci | 2023 | 37861103 | PubTator, text mining | PubMed |
| Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer. | iScience | 2023 | 37810216 | PubTator, text mining | PubMed |
| Comprehensive genomic characterization of sporadic synchronous colorectal cancer: Implications for treatment optimization and clinical outcome. | Cell Rep Med | 2023 | 37794586 | PubTator, text mining | PubMed |
| Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity. | Oncotarget | 2023 | 37791908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=4